Investor Presentaiton slide image

Investor Presentaiton

Recent Developments in USA Reimbursement Five MACS table draft local coverage determinations¹. (LCD) proposing changes to reimbursement for minimally invasive glaucoma surgeries (MIGS). On 31 October 2023 WPS issued a "final" LCD and on 9 November the other 4 MACS did the same. They are required to give 45 days' notice, making the effective date 23 December 2023. On 8 December 2023 the effective date of the LCDs was shifted to 29 January 2024. يع July 2023 Aug 2023 Sep 2023 Oct 2023 Nov 2023 Dec 2023 Jan 2024 An LCD is a determination made on coverage made that applies to the region for which the MAC is responsible. Among other changes, the final LCDs designated canaloplasty as "investigational" and would not be reimbursed. Nova Eye immediately activated near-term initiatives designed to overcome the challenges imposed by the proposed LCD changes to reduce the expected impact on sales revenue and provided support to doctors and professional bodies to lobby against the changes. On 29 December 2023, the LCDs were withdrawn and reimbursement for canaloplasty to continue unchanged. 1. In 2020, by Palmetto, issued a draft LCD and it was eventually with drawn without making it the "final". nova-eye.com | 31
View entire presentation